A new trading day began on Friday, with Vor Biopharma Inc (NASDAQ: VOR) stock price up 8.23% from the previous day of trading, before settling in for the closing price of $2.31. VOR’s price has ranged from $0.13 to $3.29 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -38.02% over the last five years. Meanwhile, its annual earnings per share averaged 56.45%. With a float of $76.86 million, this company’s outstanding shares have now reached $124.85 million.
The firm has a total of 159 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vor Biopharma Inc (VOR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vor Biopharma Inc is 38.49%, while institutional ownership is 42.14%. The most recent insider transaction that took place on Jul 10 ’25, was worth 1,388,091. Before that another transaction happened on Jul 02 ’25, when Company’s Officer proposed sale 44,936 for $1.79, making the entire transaction worth $80,435.
Vor Biopharma Inc (VOR) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 56.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.66% during the next five years compared to -38.02% drop over the previous five years of trading.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Here are Vor Biopharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Analysing the last 5-days average volume posted by the [Vor Biopharma Inc, VOR], we can find that recorded value of 25.63 million was better than the volume posted last year of 8.4 million. As of the previous 9 days, the stock’s Stochastic %D was 64.53%.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 74.99%, which indicates a significant increase from 74.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.52 in the past 14 days, which was higher than the 0.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.63, while its 200-day Moving Average is $0.87. Now, the first resistance to watch is $2.79. This is followed by the second major resistance level at $3.09. The third major resistance level sits at $3.33. If the price goes on to break the first support level at $2.25, it is likely to go to the next support level at $2.01. Should the price break the second support level, the third support level stands at $1.71.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
With a market capitalization of 312.40 million, the company has a total of 124,960K Shares Outstanding. Currently, annual sales are 0 K while annual income is -116,914 K. The company’s previous quarter sales were 0 K while its latest quarter income was -32,486 K.
